Qingdao Haier Biomedical Co.,Ltd

SHSE:688139 Stock Report

Market Cap: CN¥10.4b

Qingdao Haier BiomedicalLtd Past Earnings Performance

Past criteria checks 2/6

Qingdao Haier BiomedicalLtd has been growing earnings at an average annual rate of 6.8%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 17.6% per year. Qingdao Haier BiomedicalLtd's return on equity is 8%, and it has net margins of 16%.

Key information

6.8%

Earnings growth rate

4.6%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate17.6%
Return on equity8.0%
Net Margin16.0%
Last Earnings Update30 Sep 2024

Recent past performance updates

Qingdao Haier BiomedicalLtd's (SHSE:688139) Weak Earnings May Only Reveal A Part Of The Whole Picture

Nov 06
Qingdao Haier BiomedicalLtd's (SHSE:688139) Weak Earnings May Only Reveal A Part Of The Whole Picture

Recent updates

Qingdao Haier BiomedicalLtd's (SHSE:688139) Weak Earnings May Only Reveal A Part Of The Whole Picture

Nov 06
Qingdao Haier BiomedicalLtd's (SHSE:688139) Weak Earnings May Only Reveal A Part Of The Whole Picture

Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Stock Rockets 38% But Many Are Still Ignoring The Company

Oct 03
Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Stock Rockets 38% But Many Are Still Ignoring The Company

What Is Qingdao Haier Biomedical Co.,Ltd's (SHSE:688139) Share Price Doing?

Sep 23
What Is Qingdao Haier Biomedical Co.,Ltd's (SHSE:688139) Share Price Doing?

A Piece Of The Puzzle Missing From Qingdao Haier Biomedical Co.,Ltd's (SHSE:688139) Share Price

Aug 19
A Piece Of The Puzzle Missing From Qingdao Haier Biomedical Co.,Ltd's (SHSE:688139) Share Price

Is Qingdao Haier BiomedicalLtd (SHSE:688139) A Risky Investment?

Jun 14
Is Qingdao Haier BiomedicalLtd (SHSE:688139) A Risky Investment?

Is Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Potentially Undervalued?

May 21
Is Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Potentially Undervalued?

Further Upside For Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Shares Could Introduce Price Risks After 33% Bounce

Apr 26
Further Upside For Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Shares Could Introduce Price Risks After 33% Bounce

Further Upside For Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Shares Could Introduce Price Risks After 33% Bounce

Apr 26
Further Upside For Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Shares Could Introduce Price Risks After 33% Bounce

Revenue & Expenses Breakdown

How Qingdao Haier BiomedicalLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:688139 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242,237358537302
30 Jun 242,234362522307
31 Mar 242,281406529318
31 Dec 232,281406527321
30 Sep 232,615497518324
30 Jun 232,867579524316
31 Mar 232,987625527304
31 Dec 222,864601514292
30 Sep 222,681608463274
30 Jun 222,466573460278
31 Mar 222,276539412263
31 Dec 212,126845385236
30 Sep 211,941807343217
30 Jun 211,735799294185
31 Mar 211,549732271166
31 Dec 201,402381240151
30 Sep 201,266321236147
30 Jun 201,166254237133
31 Mar 201,078223233126
31 Dec 191,013182224121
30 Sep 19952173210103
31 Dec 1884211423287
31 Dec 176216018681
31 Dec 164821238434

Quality Earnings: 688139 has high quality earnings.

Growing Profit Margin: 688139's current net profit margins (16%) are lower than last year (19%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 688139's earnings have grown by 6.8% per year over the past 5 years.

Accelerating Growth: 688139's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 688139 had negative earnings growth (-27.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).


Return on Equity

High ROE: 688139's Return on Equity (8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies